671 related articles for article (PubMed ID: 18355314)
1. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
[TBL] [Abstract][Full Text] [Related]
2. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein.
Schlumpberger M; Wille H; Baldwin MA; Butler DA; Herskowitz I; Prusiner SB
Protein Sci; 2000 Mar; 9(3):440-51. PubMed ID: 10752606
[TBL] [Abstract][Full Text] [Related]
3. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
4. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
5. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
6. High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation.
Torrent J; Alvarez-Martinez MT; Harricane MC; Heitz F; Liautard JP; Balny C; Lange R
Biochemistry; 2004 Jun; 43(22):7162-70. PubMed ID: 15170353
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M
Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239
[TBL] [Abstract][Full Text] [Related]
8. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.
Jones EM; Surewicz WK
Cell; 2005 Apr; 121(1):63-72. PubMed ID: 15820679
[TBL] [Abstract][Full Text] [Related]
9. Amyloid fibrils formation and amorphous aggregation in concanavalin A.
Vetri V; Canale C; Relini A; Librizzi F; Militello V; Gliozzi A; Leone M
Biophys Chem; 2007 Jan; 125(1):184-90. PubMed ID: 16934387
[TBL] [Abstract][Full Text] [Related]
10. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
Nandi PK; Nicole JC
J Mol Biol; 2004 Nov; 344(3):827-37. PubMed ID: 15533448
[TBL] [Abstract][Full Text] [Related]
11. Water-soluble beta-sheet models which self-assemble into fibrillar structures.
Janek K; Behlke J; Zipper J; Fabian H; Georgalis Y; Beyermann M; Bienert M; Krause E
Biochemistry; 1999 Jun; 38(26):8246-52. PubMed ID: 10387070
[TBL] [Abstract][Full Text] [Related]
12. Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways.
Natalello A; Prokorov VV; Tagliavini F; Morbin M; Forloni G; Beeg M; Manzoni C; Colombo L; Gobbi M; Salmona M; Doglia SM
J Mol Biol; 2008 Sep; 381(5):1349-61. PubMed ID: 18619462
[TBL] [Abstract][Full Text] [Related]
13. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.
Kazlauskaite J; Young A; Gardner CE; Macpherson JV; Vénien-Bryan C; Pinheiro TJ
Biochem Biophys Res Commun; 2005 Mar; 328(1):292-305. PubMed ID: 15670783
[TBL] [Abstract][Full Text] [Related]
14. Prion protein alpha-to-beta transition monitored by time-resolved Fourier transform infrared spectroscopy.
Ollesch J; Künnemann E; Glockshuber R; Gerwert K
Appl Spectrosc; 2007 Oct; 61(10):1025-31. PubMed ID: 17958950
[TBL] [Abstract][Full Text] [Related]
15. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
Leliveld SR; Stitz L; Korth C
Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
[TBL] [Abstract][Full Text] [Related]
16. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.
Apetri AC; Vanik DL; Surewicz WK
Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190
[TBL] [Abstract][Full Text] [Related]
18. Alternative prion structural changes revealed by high pressure.
Torrent J; Alvarez-Martinez MT; Heitz F; Liautard JP; Balny C; Lange R
Biochemistry; 2003 Feb; 42(5):1318-25. PubMed ID: 12564935
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
Nazabal A; Hornemann S; Aguzzi A; Zenobi R
J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
[TBL] [Abstract][Full Text] [Related]
20. Fibrillar beta-lactoglobulin gels: Part 1. Fibril formation and structure.
Gosal WS; Clark AH; Ross-Murphy SB
Biomacromolecules; 2004; 5(6):2408-19. PubMed ID: 15530058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
